Article Information
History
- July 16, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Henne Holstege1,2,3,4,*,#,
- Matthijs W. J. de Waal1,4,*,
- Niccolo Tesi1,2,4,
- Sven J. van der Lee1,3,4,
- ADES-consortium,
- ADSP consortium,
- StEP-AD consortium,
- Knight-ADRC,
- UCSF/NYGC/UAB,
- Maartje Vogel5,
- Resie van Spaendonk5,
- Marc Hulsman1,2,4 and
- Olav M. Andersen6,*
- 1Section Genomics of Neurodegenerative Diseases and Aging, Department of Clinical Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
- 2Delft Bioinformatics Lab, Delft University of Technology, Delft, The Netherlands
- 3Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands
- 4Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands
- 5Dept. of Human Genetics, Genome Diagnostics Laboratory, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands
- 6Dept. of Biomedicine, Aarhus University, Denmark
- ↵#Corresponding Author: Henne Holstege, h.holstege{at}amsterdam.nl
↵* Authors contributed equally to this work.
Posted July 16, 2023.
Effect of prioritized SORL1 missense variants supports clinical consideration for familial Alzheimer’s Disease
